These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23267829)
1. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. Shang B; Deng C; Ye H; Xu W; Yuan Z; Shi PY; Zhang B Antiviral Res; 2013 Feb; 97(2):198-205. PubMed ID: 23267829 [TBL] [Abstract][Full Text] [Related]
2. Development of a stable Gaussia luciferase enterovirus 71 reporter virus. Xu LL; Shan C; Deng CL; Li XD; Shang BD; Ye HQ; Liu SQ; Yuan ZM; Wang QY; Shi PY; Zhang B J Virol Methods; 2015 Jul; 219():62-66. PubMed ID: 25843263 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a stable luciferase dengue virus for high-throughput screening. Zou G; Xu HY; Qing M; Wang QY; Shi PY Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658 [TBL] [Abstract][Full Text] [Related]
4. Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus. Lu CY; Hour MJ; Wang CY; Huang SH; Mu WX; Chang YC; Lin CW Viruses; 2017 Apr; 9(4):. PubMed ID: 28394283 [TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a clinical strain of Coxsackievirus A16 and an eGFP infectious clone. Deng C; Li X; Liu S; Xu L; Ye H; Qin CF; Zhang B Virol Sin; 2015 Aug; 30(4):269-76. PubMed ID: 26220729 [TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. Hung HC; Wang HC; Shih SR; Teng IF; Tseng CP; Hsu JT J Infect Dis; 2011 Jun; 203(12):1784-90. PubMed ID: 21536800 [TBL] [Abstract][Full Text] [Related]
7. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro. Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760 [TBL] [Abstract][Full Text] [Related]
8. A 3C(pro)-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents. Guo Z; Zhong X; Lin L; Wu S; Wang T; Chen Y; Zhai X; Wang Y; Wu H; Tong L; Han Y; Pan B; Peng Y; Si X; Zhang F; Zhao W; Zhong Z Antiviral Res; 2014 Jan; 101():82-92. PubMed ID: 24263113 [TBL] [Abstract][Full Text] [Related]
9. [Study on the association of hand, foot and mouth disease and enterovirus 71/CA16 among children in Beijing, 2007]. Zhu RN; Qian Y; Deng J; Xing JF; Zhao LQ; Wang F; Liao B; Ren XX; Li Y; Zhang Q; Li J Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1004-8. PubMed ID: 18399150 [TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease. Ji P; Chen C; Hu Y; Zhan Z; Pan W; Li R; Li E; Ge HM; Yang G Biol Pharm Bull; 2015; 38(1):1-6. PubMed ID: 25744451 [TBL] [Abstract][Full Text] [Related]
11. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Xu L; Su W; Jin J; Chen J; Li X; Zhang X; Sun M; Sun S; Fan P; An D; Zhang H; Zhang X; Kong W; Ma T; Jiang C Viruses; 2014 Jul; 6(7):2778-95. PubMed ID: 25036464 [TBL] [Abstract][Full Text] [Related]
12. Development of Neutralization Assay Using an eGFP Chikungunya Virus. Deng CL; Liu SQ; Zhou DG; Xu LL; Li XD; Zhang PT; Li PH; Ye HQ; Wei HP; Yuan ZM; Qin CF; Zhang B Viruses; 2016 Jun; 8(7):. PubMed ID: 27367716 [TBL] [Abstract][Full Text] [Related]
13. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Towner JS; Paragas J; Dover JE; Gupta M; Goldsmith CS; Huggins JW; Nichol ST Virology; 2005 Feb; 332(1):20-7. PubMed ID: 15661137 [TBL] [Abstract][Full Text] [Related]
14. Pyrrolidine dithiocarbamate inhibits enterovirus 71 replication by down-regulating ubiquitin-proteasome system. Lin L; Qin Y; Wu H; Chen Y; Wu S; Si X; Wang H; Wang T; Zhong X; Zhai X; Tong L; Pan B; Zhang F; Zhong Z; Wang Y; Zhao W Virus Res; 2015 Jan; 195():207-16. PubMed ID: 25456405 [TBL] [Abstract][Full Text] [Related]
15. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Zhang W; Tao J; Yang X; Yang Z; Zhang L; Liu H; Wu K; Wu J Biochem Biophys Res Commun; 2014 Jul; 449(3):307-12. PubMed ID: 24845570 [TBL] [Abstract][Full Text] [Related]
16. Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles. Yuan S; Li G; Wang Y; Gao Q; Wang Y; Cui R; Altmeyer R; Zou G J Virol; 2016 Jan; 90(2):741-52. PubMed ID: 26512078 [TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Yi L; He Y; Chen Y; Kung HF; He ML Antivir Ther; 2011; 16(1):51-8. PubMed ID: 21311108 [TBL] [Abstract][Full Text] [Related]
18. Antiviral drug discovery for the treatment of enterovirus 71 infections. Shang L; Xu M; Yin Z Antiviral Res; 2013 Feb; 97(2):183-94. PubMed ID: 23261847 [TBL] [Abstract][Full Text] [Related]
19. Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies. Liu Q; Huang X; Ku Z; Wang T; Liu F; Cai Y; Li D; Leng Q; Huang Z J Virol Methods; 2013 Jan; 187(1):127-31. PubMed ID: 23046991 [TBL] [Abstract][Full Text] [Related]
20. Construction of green fluorescent protein-tagged recombinant iridovirus to assess viral replication. Huang Y; Huang X; Cai J; Ye F; Guan L; Liu H; Qin Q Virus Res; 2011 Sep; 160(1-2):221-9. PubMed ID: 21756948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]